This is brilliant well done! Have worked w families -NICU & follow up of high risk infants and parents unwell going through treatment for other serious conditions. This supports infant mental health and families. Restores my faith in holistic family focused care

💊 Systemic treatments in advanced #angiosarcoma 🧐 Challenges conducting trials ⬇️ Systemic review by EORTC/ STBSG Eur J Can 2024 Very nice overview by Bernd Kaspar at #ESMORareCancers25 #ESMOAmbassadors

Young Onc case discussions at #ESMORareCancers25 - Sat AM ‼️ Not just for young oncs & not to be missed ‼️ Challenging & interesting cases will be presented by Andrea Franza, MD Hailey Carroll discussions by Robin Lewis Jones Herbert Loong, MBBS, FASCO Claudia Valverde Antonia Digklia 📍Hall E

An amazing final day at #ESMORareCancers25 - so grateful to receive a merit award & the opportunity to present, representing St Vincent's University Hospital (SVUH) & Cork University Hospitals 🇮🇪 Thanks to all my mentors esp Richard Bambury & Prof Mark Doherty, Prof Valverde for her expertise & #ESMOYOC for the opportunity ✨

Wonderful crew of Young Oncologists Cases Discussion session at ESMO Rare Cancers 2025 - Herbert Loong (Herbert Loong, MBBS, FASCO) oncodaily.com/blog/young-onc… #OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews #ESMORareCancers2025 #YoungOncologists

Please support Irish Cancer Society on 🌼 day today, they have been pivotal in supporting ☘️ CancerTrialsIreland 🌈 studies and 👩‍🔬 cancer research 🔬shown here 👇

Our paper in JCO Precision Oncology describes Digital Spatial Profiling analysis of HER2+ tumors, revealing novel insights into tumor & immune microenvironment -implications for biomarker discovery & tailoring of tx 💉🎯 Thanks to Roisin Connolly, Translational Breast Cancer Research Consortium Johns Hopkins Kimmel Cancer Center Breakthrough Cancer Research

Delighted to see Dr. Emily Harrold, Consultant Oncologist, St James's Hospital & Co- Director of the Young Onset Cancer Programme Trinity St James's Cancer Institute as one of the speakers at ENTERO. Emily Harrold will present on bridging the awareness gap & overcoming delayed cancer diagnosis.

🧬 Genetic Predisposition in Sarcoma Up to 20% #sarcoma may be assoc. with predisposition genes In our 📝 we review evidence on genetic predis. & how it may influence Rx decisions & management inc. surgery, radiotherapy, systemic Rx & surveillance 1/4 thelancet.com/journals/eclin…

Dr. Emily Harrold Emily Harrold Consultant Oncologist & co-director of the Young Onset Cancer Programme Trinity St James's Cancer Institute St James's Hospital speaking today at ENTERO in the European Parliament advocating for change & raising awareness of young onset cancers Nicola Keohane Maeve Lowery

On April 29th, our PRRT Team successfully administered the 100th 177Lu-DOTATATE treatment for patients with Neuro-endocrine Tumours. This innovative therapy helps improve outcomes & quality of life for our patients. Sincere thanks to our dedicated multidisciplinary team! #SVUH

Honored to represent University Health Network and @PMCancerCentre at #AATS2025. Our ctDNA Lung DETECT Study adds to the growing evidence supporting the utility of ctDNA in early-stage NSCLC #AATS25 #AATS #ctDNA

“Collaboration is the Engine of Change” 📣 Join us this Friday. Registration link 👇 🎯Increase trial options for patients Bidirectional learning from trial units ✅ National trial initiatives ✅ Workshops for future initiatives ✅ Enhancing collaborations ✅

What an amazing two days re: visit by ⁦Organisation of European Cancer Institutes⁩ accreditation team! It was fantastic to see the great team spirit from the 3 core institutions making up the St. Vincent’s UCD Cancer Centre - thanks to our visitors for making it such a pleasure and informative visit

Well done to Karine and the team on this excellent poster, which highlights the financial and resource implications of genomic testing for both healthcare institutions and patients. #ESMOBreast25

🔥NeoPancOne🇨🇦 ➡️mFFX in resectable PDAC ➡️exploring GATA6&subtypes ➡️mEFS &OS 16.3 &34.2mths ➡️1yr EFS 90% in GATA6 hi vs 50% lo ➡️1yr OS classical 95% vs.57% basal-like ⭐️Time to subtype upfront in all PDAC recognising plasticity OncoAlert #ASCO25 Ontario Institute for Cancer Research (OICR) Princess Margaret Cancer Centre

📅 Mark your calendar: ISMO After-ASCO 2025 A virtual meeting hosted by Seamus O’Reilly MD PhD & Michaela Higgins to share key insights from #ASCO25. 🗓️ Tuesday 15 July | 6–8 PM Irish time 💻 Supported by Cancer Trials Ireland 🔗 Register now: bit.ly/4mSF64s

Congrats to oncology trainee Mary O’Reilly presenting data from her PhD on early onset colorectal cancer at ESMO GI 2025 ESMO - Eur. Oncology Ray McDermott Grainne O'Kane St Vincent's University Hospital (SVUH)

Developing and conducting the Irish Cancer Society LYSA study has been a fantastic opportunity for our team -also supported by HealthResearchBoard funded UCC Cancer Trials Group Breakthrough Cancer Research CRF-UCC HRB Clinical Research Galway and hospital sites. Most importantly- great support to patients. 🙏

To ensure end-of-life care is the best it can be teams at Marymount Hospice & Cork University Hospitals introduced a care planning form, checklist & staff training to improve how dying patients and families are supported. 📰mdpi.com/1718-7729/32/8…